The administration of pioglitazone [34] and the AT1 receptor antagonist (L-158,809) [35] for a short time (4 or 5 weeks) postirradiation is sufficient to prevent cognitive impairments. This evidence concerns the gene AGTR1 and Cognitive impairment.